Ontology highlight
ABSTRACT: Introduction
The safety profiles of COVID-19 vaccines are incompletely evaluated in Japan.Objectives
To examine the risk of serious adverse effects after COVID-19 mRNA vaccination (BNT162b2 and mRNA-1273) in cohort studies and self-controlled case series (SCCS).Methods
Using an administrative claims database linked with the COVID-19 vaccination registry in a city in Japan between September 2020 and September 2021, we identified health insurance enrolees aged ≥ 18 years. We evaluated the risk of acute myocardial infarction, appendicitis, Bell's palsy, convulsions/seizures, disseminated intravascular coagulation, immune thrombocytopenia, pulmonary embolism, haemorrhagic or ischemic stroke, venous thromboembolism, and all-cause mortality, 21 days following any COVID-19
SUBMITTER: Takeuchi Y
PROVIDER: S-EPMC9637511 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature